Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 630

1.

Quality of life and treatment goals in psoriasis from the patient perspective: results of an Austrian cross-sectional survey.

Wolf P, Weger W, Legat F, Painsi C, Saxinger W, Müllegger R, Sator P, Ratzinger G, Selhofer S, Richter L, Salmhofer W, Lange-Asschenfeldt B, Trautinger F, Mlynek A, Strohal R, Augustin M, Quehenberger F.

J Dtsch Dermatol Ges. 2018 Aug;16(8):981-990. doi: 10.1111/ddg.13613.

PMID:
30117711
2.

Lebensqualität und Behandlungsziele bei Psoriasis aus Patientensicht: Ergebnisse eines österreichweiten Querschnitt-Survey.

Wolf P, Weger W, Legat F, Painsi C, Saxinger W, Müllegger R, Sator P, Ratzinger G, Selhofer S, Richter L, Salmhofer W, Lange-Asschenfeldt B, Trautinger F, Mlynek A, Strohal R, Augustin M, Quehenberger F.

J Dtsch Dermatol Ges. 2018 Aug;16(8):981-991. doi: 10.1111/ddg.13613_g.

PMID:
30117699
3.

Antidepressants in breast milk; comparative analysis of excretion ratios.

Schoretsanitis G, Augustin M, Saßmannshausen H, Franz C, Gründer G, Paulzen M.

Arch Womens Ment Health. 2018 Aug 16. doi: 10.1007/s00737-018-0905-3. [Epub ahead of print]

PMID:
30116895
4.

[Improved quality of healthcare through dermatological health services research : Effects of structured programs on psoriasis and skin cancer].

Gehoff M, Augustin M.

Hautarzt. 2018 Aug 16. doi: 10.1007/s00105-018-4243-1. [Epub ahead of print] Review. German.

PMID:
30116831
5.

How to Treat Hypertension in Venlafaxine-Medicated Patients-Pharmacokinetic Considerations in Prescribing Amlodipine and Ramipril.

Augustin M, Schoretsanitis G, Gründer G, Haen E, Paulzen M.

J Clin Psychopharmacol. 2018 Aug 10. doi: 10.1097/JCP.0000000000000929. [Epub ahead of print]

PMID:
30102628
6.

Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials.

Gordon KB, Strober B, Lebwohl M, Augustin M, Blauvelt A, Poulin Y, Papp KA, Sofen H, Puig L, Foley P, Ohtsuki M, Flack M, Geng Z, Gu Y, Valdes JM, Thompson EHZ, Bachelez H.

Lancet. 2018 Aug 7. pii: S0140-6736(18)31713-6. doi: 10.1016/S0140-6736(18)31713-6. [Epub ahead of print]

PMID:
30097359
7.

[Health Atlases in Germany - An Overview].

Augustin J, Scherer M, Augustin M, Schweikart J.

Gesundheitswesen. 2018 Jul;80(7):628-634. doi: 10.1055/a-0631-1168. Epub 2018 Jul 25. German.

PMID:
30045387
8.

Tracking Tregs: Translocation of CD49b/LAG-3+ Type 1 regulatory T cells to the Gut-Associated Lymphoid Tissue of HIV+ patients.

Augustin M, Horn C, Koch J, Sandaradura de Silva U, Platten M, Nierhoff D, Suarez I, Chon SH, Rybniker J, Lehmann C.

AIDS Res Hum Retroviruses. 2018 Jul 18. doi: 10.1089/AID.2018.0052. [Epub ahead of print]

PMID:
30019612
9.

Praxis der Teledermatologie.

Augustin M, Wimmer J, Biedermann T, Blaga R, Dierks C, Djamei V, Elmer A, Elsner P, Enk A, Gass S, Henningsen M, Hofman-Wellenhof R, von Kiedrowski R, Kunz HD, Liebram C, Navarini A, Otten M, Reusch M, Schüller C, Zink A, Strömer K.

J Dtsch Dermatol Ges. 2018 Jul;16 Suppl 5:6-57. doi: 10.1111/ddg.13512.

PMID:
29998512
10.

Positionspapier: Diagnostik und Therapie der Xerosis cutis.

Augustin M, Wilsmann-Theis D, Körber A, Kerscher M, Itschert G, Dippel M, Staubach P.

J Dtsch Dermatol Ges. 2018 Jul;16 Suppl 4:3-35. doi: 10.1111/ddg.13580.

PMID:
29989340
11.

Prevalence, predictors and comorbidity of dry skin in the general population.

Augustin M, Kirsten N, Körber A, Wilsmann-Theis D, Itschert G, Staubach-Renz P, Maul JT, Zander N.

J Eur Acad Dermatol Venereol. 2018 Jun 28. doi: 10.1111/jdv.15157. [Epub ahead of print]

PMID:
29953684
12.

Discovery of a Potent, Orally Bioavailable PI4KIIIβ Inhibitor (UCB9608) Able To Significantly Prolong Allogeneic Organ Engraftment in Vivo.

Reuberson J, Horsley H, Franklin RJ, Ford D, Neuss J, Brookings D, Huang Q, Vanderhoydonck B, Gao LJ, Jang MY, Herdewijn P, Ghawalkar A, Fallah-Arani F, Khan AR, Henshall J, Jairaj M, Malcolm S, Ward E, Shuttleworth L, Lin Y, Li S, Louat T, Waer M, Herman J, Payne A, Ceska T, Doyle C, Pitt W, Calmiano M, Augustin M, Steinbacher S, Lammens A, Allen R.

J Med Chem. 2018 Aug 9;61(15):6705-6723. doi: 10.1021/acs.jmedchem.8b00521. Epub 2018 Jul 19.

PMID:
29952567
13.

How to weight patient-relevant treatment goals for assessing treatment benefit in psoriasis: preference elicitation methods vs. rating scales.

Gutknecht M, Schaarschmidt ML, Danner M, Otten M, Augustin M.

Arch Dermatol Res. 2018 Jun 23. doi: 10.1007/s00403-018-1846-4. [Epub ahead of print]

PMID:
29934781
14.

Validation of a short form FLQA-LS quality of life instrument for lymphedema.

Augustin M, Conde Montero E, Hagenström K, Herberger K, Blome C.

Br J Dermatol. 2018 Jun 21. doi: 10.1111/bjd.16902. [Epub ahead of print]

PMID:
29927481
15.

The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy: a survey in German melanoma patients and their treating physicians.

Kähler KC, Blome C, Forschner A, Gutzmer R, Hauschild A, Heinzerling L, Livingstone E, Loquai C, Müller-Brenne T, Schadendorf D, Utikal J, Wagner T, Augustin M.

Oncotarget. 2018 May 25;9(40):26217-26225. doi: 10.18632/oncotarget.25439. eCollection 2018 May 25.

16.

Was ist Schuppenflechte? - Wahrnehmung und Bewertung der Psoriasis in der deutschen Bevölkerung.

Sommer R, Mrowietz U, Radtke MA, Schäfer I, von Kiedrowski R, Strömer K, Enk A, Maul JT, Reich K, Zander N, Augustin M.

J Dtsch Dermatol Ges. 2018 Jun;16(6):703-710. doi: 10.1111/ddg.13539_g.

PMID:
29873919
17.

S3 Guideline for the treatment of psoriasis vulgaris, update - Short version part 2 - Special patient populations and treatment situations.

Nast A, Amelunxen L, Augustin M, Boehncke WH, Dressler C, Gaskins M, Härle P, Hoffstadt B, Klaus J, Koza J, Mrowietz U, Ockenfels HM, Philipp S, Reich K, Rosenbach T, Rzany B, Schlaeger M, Schmid-Ott G, Sebastian M, von Kiedrowski R, Weberschock T.

J Dtsch Dermatol Ges. 2018 Jun;16(6):806-813. doi: 10.1111/ddg.13538.

PMID:
29873906
18.

S3-Leitlinie zur Therapie der Psoriasis vulgaris Update - Kurzfassung Teil 2 - Besondere Patientengruppen und spezielle Behandlungssituationen.

Nast A, Amelunxen L, Augustin M, Boehncke WH, Dressler C, Gaskins M, Härle P, Hoffstadt B, Klaus J, Koza J, Mrowietz U, Ockenfels HM, Philipp S, Reich K, Rosenbach T, Rzany B, Schlaeger M, Schmid-Ott G, Sebastian M, von Kiedrowski R, Weberschock T.

J Dtsch Dermatol Ges. 2018 Jun;16(6):806-814. doi: 10.1111/ddg.13538_g.

PMID:
29873903
19.

What is psoriasis? - Perception and assessment of psoriasis among the German population.

Sommer R, Mrowietz U, Radtke MA, Schäfer I, von Kiedrowski R, Strömer K, Enk A, Maul JT, Reich K, Zander N, Augustin M.

J Dtsch Dermatol Ges. 2018 Jun;16(6):703-710. doi: 10.1111/ddg.13539.

PMID:
29873901
20.

Phytosterol crystallisation within bulk and dispersed triacylglycerol matrices as influenced by oil droplet size and low molecular weight surfactant addition.

Zychowski LM, Logan A, Augustin MA, Kelly AL, O'Mahony JA, Conn CE, Auty MAE.

Food Chem. 2018 Oct 30;264:24-33. doi: 10.1016/j.foodchem.2018.04.026. Epub 2018 Apr 12.

PMID:
29853371
21.

Minimal clinically important difference (MCID) for work productivity and activity impairment (WPAI) questionnaire in psoriasis patients.

Wu JJ, Lin C, Sun L, Goldblum O, Zbrozek A, Burge R, Augustin M, Feldman SR.

J Eur Acad Dermatol Venereol. 2018 May 30. doi: 10.1111/jdv.15098. [Epub ahead of print]

PMID:
29846976
22.

Association of the Quick Sequential (Sepsis-Related) Organ Failure Assessment (qSOFA) Score With Excess Hospital Mortality in Adults With Suspected Infection in Low- and Middle-Income Countries.

Rudd KE, Seymour CW, Aluisio AR, Augustin ME, Bagenda DS, Beane A, Byiringiro JC, Chang CH, Colas LN, Day NPJ, De Silva AP, Dondorp AM, Dünser MW, Faiz MA, Grant DS, Haniffa R, Van Hao N, Kennedy JN, Levine AC, Limmathurotsakul D, Mohanty S, Nosten F, Papali A, Patterson AJ, Schieffelin JS, Shaffer JG, Thuy DB, Thwaites CL, Urayeneza O, White NJ, West TE, Angus DC; Sepsis Assessment and Identification in Low Resource Settings (SAILORS) Collaboration.

JAMA. 2018 Jun 5;319(21):2202-2211. doi: 10.1001/jama.2018.6229.

PMID:
29800114
23.

Willingness to pay for a cure of low-risk melanoma patients in Germany.

Augustin M, Blome C, Forschner A, Gutzmer R, Hauschild A, Heinzerling L, Livingstone E, Loquai C, Schadendorf D, Utikal J, Wagner T, Wilden S, Kähler KC.

PLoS One. 2018 May 24;13(5):e0197780. doi: 10.1371/journal.pone.0197780. eCollection 2018.

24.

Measurement of healthcare quality in atopic dermatitis - development and application of a set of quality indicators.

Steinke S, Beikert FC, Langenbruch A, Fölster-Holst R, Ring J, Schmitt J, Werfel T, Hintzen S, Franzke N, Augustin M.

J Eur Acad Dermatol Venereol. 2018 May 15. doi: 10.1111/jdv.15074. [Epub ahead of print]

PMID:
29763514
25.

White light polarization sensitive optical coherence tomography for sub-micron axial resolution and spectroscopic contrast in the murine retina.

Harper DJ, Augustin M, Lichtenegger A, Eugui P, Reyes C, Glösmann M, Hitzenberger CK, Baumann B.

Biomed Opt Express. 2018 Apr 5;9(5):2115-2129. doi: 10.1364/BOE.9.002115. eCollection 2018 May 1.

26.

S3-Leitlinie zur Therapie der Psoriasis vulgaris Update - Kurzfassung Teil 1 - Systemische Therapie.

Nast A, Amelunxen L, Augustin M, Boehncke WH, Dressler C, Gaskins M, Härle P, Hoffstadt B, Klaus J, Koza J, Mrowietz U, Ockenfels HM, Philipp S, Reich K, Rosenbach T, Rzany B, Schlaeger M, Schmid-Ott G, Sebastian M, von Kiedrowski R, Weberschock T.

J Dtsch Dermatol Ges. 2018 May;16(5):645-670. doi: 10.1111/ddg.13516_g. No abstract available.

PMID:
29750455
27.

S3 Guideline for the treatment of psoriasis vulgaris, update - Short version part 1 - Systemic treatment.

Nast A, Amelunxen L, Augustin M, Boehncke WH, Dressler C, Gaskins M, Härle P, Hoffstadt B, Klaus J, Koza J, Mrowietz U, Ockenfels HM, Philipp S, Reich K, Rosenbach T, Rzany B, Schlaeger M, Schmid-Ott G, Sebastian M, von Kiedrowski R, Weberschock T.

J Dtsch Dermatol Ges. 2018 May;16(5):645-669. doi: 10.1111/ddg.13516.

PMID:
29750443
28.

Correlation of psoriasis activity with socioeconomic status: cross-sectional analysis of patients enrolled in the Psoriasis Longitudinal Assessment and Registry (PSOLAR).

Kimball AB, Augustin M, Gordon KB, Krueger GG, Pariser D, Fakharzadeh S, Goyal K, Calabro S, Lee S, Lin R, Li N, Srivastava B, Guenther L.

Br J Dermatol. 2018 May 10. doi: 10.1111/bjd.16737. [Epub ahead of print] No abstract available.

PMID:
29747219
29.

Prurigo Activity Score (PAS): validity and reliability of a new instrument to monitor chronic prurigo.

Pölking J, Zeidler C, Schedel F, Osada N, Augustin M, Metze D, Pereira MP, Yosipovitch G, Bernhard JD, Ständer S.

J Eur Acad Dermatol Venereol. 2018 May 5. doi: 10.1111/jdv.15040. [Epub ahead of print]

PMID:
29729201
30.

Cost-effectiveness of secukinumab as first biologic treatment, compared with other biologics, for moderate to severe psoriasis in Germany.

Augustin M, McBride D, Gilloteau I, O'Neill C, Neidhardt K, Graham CN.

J Eur Acad Dermatol Venereol. 2018 May 5. doi: 10.1111/jdv.15047. [Epub ahead of print]

PMID:
29729105
31.

Reduced clearance of venlafaxine in a combined treatment with quetiapine.

Paulzen M, Schoretsanitis G, Hiemke C, Gründer G, Haen E, Augustin M.

Prog Neuropsychopharmacol Biol Psychiatry. 2018 Jul 13;85:116-121. doi: 10.1016/j.pnpbp.2018.04.014. Epub 2018 Apr 25.

PMID:
29702137
32.

[Compression bandages with and without padding : Observational controlled survey of pressure and comfort].

Protz K, Reich-Schupke S, Müller K, Augustin M, Hagenström K.

Hautarzt. 2018 Aug;69(8):653-661. doi: 10.1007/s00105-018-4167-9. German.

PMID:
29696354
33.

In Vivo Characterization of Spontaneous Retinal Neovascularization in the Mouse Eye by Multifunctional Optical Coherence Tomography.

Augustin M, Wechdorn M, Pfeiffenberger U, Himmel T, Fialová S, Werkmeister RM, Hitzenberger CK, Glösmann M, Baumann B.

Invest Ophthalmol Vis Sci. 2018 Apr 1;59(5):2054-2068. doi: 10.1167/iovs.17-23208.

PMID:
29677368
34.

Compact akinetic swept source optical coherence tomography angiography at 1060 nm supporting a wide field of view and adaptive optics imaging modes of the posterior eye.

Salas M, Augustin M, Felberer F, Wartak A, Laslandes M, Ginner L, Niederleithner M, Ensher J, Minneman MP, Leitgeb RA, Drexler W, Levecq X, Schmidt-Erfurth U, Pircher M.

Biomed Opt Express. 2018 Mar 26;9(4):1871-1892. doi: 10.1364/BOE.9.001871. eCollection 2018 Apr 1.

35.

Certolizumab pegol for the treatment of chronic plaque psoriasis: Results through 48 weeks of a phase 3, multicenter, randomized, double-blind, etanercept- and placebo-controlled study (CIMPACT).

Lebwohl M, Blauvelt A, Paul C, Sofen H, Węgłowska J, Piguet V, Burge D, Rolleri R, Drew J, Peterson L, Augustin M.

J Am Acad Dermatol. 2018 Aug;79(2):266-276.e5. doi: 10.1016/j.jaad.2018.04.013. Epub 2018 Apr 14.

36.

Epidemiology of skin cancer in the German population: impact of socioeconomic and geographic factors.

Augustin J, Kis A, Sorbe C, Schäfer I, Augustin M.

J Eur Acad Dermatol Venereol. 2018 Apr 6. doi: 10.1111/jdv.14990. [Epub ahead of print]

PMID:
29633375
37.

Characterisation of β-carotene partitioning in protein emulsions: Effects of pre-treatments, solid fat content and emulsifier type.

Wan Mohamad WAF, McNaughton D, Augustin MA, Buckow R.

Food Chem. 2018 Aug 15;257:361-367. doi: 10.1016/j.foodchem.2018.03.027. Epub 2018 Mar 9.

PMID:
29622223
38.

Correction to: Efficacy and Safety of Switching to Ixekizumab in Etanercept Non-Responders: A Subanalysis from Two Phase III Randomized Clinical Trials in Moderate-to-Severe Plaque Psoriasis (UNCOVER-2 and -3).

Blauvelt A, Papp KA, Griffiths CEM, Puig L, Weisman J, Dutronc Y, Kerr LF, Ilo D, Mallbris L, Augustin M.

Am J Clin Dermatol. 2018 Jun;19(3):457. doi: 10.1007/s40257-018-0353-x.

39.

Measuring the importance of health domains in psoriasis - discrete choice experiment versus rating scales.

Gutknecht M, Schaarschmidt ML, Danner M, Blome C, Augustin M.

Patient Prefer Adherence. 2018 Mar 15;12:363-373. doi: 10.2147/PPA.S152509. eCollection 2018.

40.

[Side effects of biologic therapies in psoriasis].

Altenburg A, Augustin M, Zouboulis CC.

Hautarzt. 2018 Apr;69(4):290-297. doi: 10.1007/s00105-018-4156-z. Review. German.

PMID:
29568996
41.

European Multicenter Study for the Evaluation of a Dual-Layer Flow-Diverting Stent for Treatment of Wide-Neck Intracranial Aneurysms: The European Flow-Redirection Intraluminal Device Study.

Killer-Oberpfalzer M, Kocer N, Griessenauer CJ, Janssen H, Engelhorn T, Holtmannspötter M, Buhk JH, Finkenzeller T, Fesl G, Trenkler J, Reith W, Berlis A, Hausegger K, Augustin M, Islak C, Minnich B, Möhlenbruch M.

AJNR Am J Neuroradiol. 2018 May;39(5):841-847. doi: 10.3174/ajnr.A5592. Epub 2018 Mar 15.

PMID:
29545252
42.

S2k guidelines for the use of topical preparations on the skin.

Wohlrab J, Staubach P, Augustin M, Eisert L, Hünerbein A, Nast A, Reimann H, Strömer K, Mahler V.

J Dtsch Dermatol Ges. 2018 Mar;16(3):376-392. doi: 10.1111/ddg.13473.

PMID:
29537159
43.

S2k-Leitlinie zum Gebrauch von Präparationen zur lokalen Anwendung auf der Haut (Topika).

Wohlrab J, Staubach P, Augustin M, Eisert L, Hünerbein A, Nast A, Reimann H, Strömer K, Mahler V.

J Dtsch Dermatol Ges. 2018 Mar;16(3):376-392. doi: 10.1111/ddg.13473_g.

PMID:
29537157
44.

Patient-dermatologist agreement in psoriasis severity, symptoms and satisfaction: results from a real-world multinational survey.

Griffiths CEM, Augustin M, Naldi L, Romiti R, Guevara-Sangines E, Howe T, Pietri G, Gilloteau I, Richardson C, Tian H, Jo SJ.

J Eur Acad Dermatol Venereol. 2018 Mar 10. doi: 10.1111/jdv.14937. [Epub ahead of print]

PMID:
29524271
45.

Postsurgical Treatment of Split Skin Graft Donor Sites in Dermatological Departments.

Jansen P, Stoffels I, Klode J, Jockenhöfer F, Augustin M, Schadendorf D, Dissemond J.

Int J Low Extrem Wounds. 2018 Mar;17(1):22-29. doi: 10.1177/1534734617747685. Epub 2018 Mar 5.

PMID:
29502480
46.

Assessing the Importance of Treatment Goals in Patients with Psoriasis: Analytic Hierarchy Process vs. Likert Scales.

Gutknecht M, Danner M, Schaarschmidt ML, Gross C, Augustin M.

Patient. 2018 Aug;11(4):425-437. doi: 10.1007/s40271-018-0300-1.

PMID:
29450833
47.

Rapid improvement of psoriasis in a patient with lung cancer after treatment with erlotinib.

Goepel L, Jacobi A, Augustin M, Radtke MA.

J Eur Acad Dermatol Venereol. 2018 Feb 11. doi: 10.1111/jdv.14862. [Epub ahead of print] No abstract available.

PMID:
29430731
48.

Variation in the diagnosis and clinical management of lentigo maligna across Europe: a survey study among European Association of Dermatologists and Venereologists members.

Tio D, Prinsen CAC, Dréno B, Hoekzema R, Augustin M, van Montfrans C.

J Eur Acad Dermatol Venereol. 2018 Feb 8. doi: 10.1111/jdv.14850. [Epub ahead of print]

PMID:
29419913
49.

Biosimilars in der Dermatologie - Theorie wird Realität.

Gerdes S, Mrowietz U, Augustin M, von Kiedrowski R, Enk A, Strömer K, Schön MP, Radtke MA.

J Dtsch Dermatol Ges. 2018 Feb;16(2):150-162. doi: 10.1111/ddg.13410_g. Review.

PMID:
29418106
50.

[Prevalence of dermatomycoses in professional football players : A study based on data of German Bundesliga fitness check-ups (2013-2015) compared to data of the general population].

Buder V, Augustin M, Schäfer I, Welsch G, Catala-Lehnen P, Herberger K.

Hautarzt. 2018 May;69(5):401-407. doi: 10.1007/s00105-017-4120-3. German.

PMID:
29417157

Supplemental Content

Loading ...
Support Center